22.12.2015 13:42:32
|
Evogene Names Eyal Leibovitz As CFO, Effective Jan 1, 2016
(RTTNews) - Evogene Ltd. (EVGN), working for the improvement of crop productivity and economics for the food, feed and fuel industries, announced the appointment of Eyal Leibovitz as Chief Financial Officer.
Leibovitz is joining the company effective January 1, 2016 and will replace Sigal Fattal who has been with the company since June 2012 and will remain until January 31, 2016 to ensure a smooth transition.
Fattal will continue to support the company after her departure and until April 2016. Leibovitz will report to Ofer Haviv, Evogene's President and Chief Executive Officer, and will have executive responsibility for all corporate functions of the company.
Leibovitz brings with him an extensive background in senior management, finance, investor relations, M&A and business development in international companies.
In his last role he served as CFO and member of the executive committee of N-trig Ltd., an electronic inking company. Prior to this, from 2007 to 2011 Leibovitz served as the CFO of Kamada Ltd. (KMDA).
From 2002 to 2007, Leibovitz served as the International controller of Harmonic Inc., headquartered in California and operating in the digital video space.
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Evogene Ltdmehr Nachrichten
20.11.24 |
Ausblick: Evogene verkündet Quartalsergebnis zum jüngsten Jahresviertel (finanzen.net) | |
21.08.24 |
Ausblick: Evogene stellt das Zahlenwerk zum vergangenen Quartal vor (finanzen.net) |
Analysen zu Evogene Ltdmehr Analysen
Aktien in diesem Artikel
Evogene Ltd | 1,85 | -2,63% |